Trending Now
Novavax (NASDAQ:NVAX) Signs Supply Agreement To Supply 40 Million Doses To...
Novavax (NASDAQ:NVAX) has signed an agreement with the Australian government to supply 40 million doses of its coronavirus vaccine candidate.
Novavax expects clinical results of...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Is TSLA stock heading back to the 300 level ?
Investors have regained interest in the tech sector, which was one of the worst-performing sectors in 2022. The tech-heavy Nasdaq Composite has...
MAKE IT MODERN
LATEST REVIEWS
Portage Biotech (PRTG): A Year of Strategic Shifts and Financial Reassessment
Portage Biotech Inc. (NASDAQ: PRTG), a notable player in the immuno-oncology field, has disclosed its fiscal results for the year ending March...
MAKE IT MODERN
PERFORMANCE TRAINING
Sorrento Therapeutics Inc (NASDAQ: SRNE) Takes Over ACEA Therapeutics Inc For $38 Million: Inks...
Sorrento Therapeutics Inc (NASDAQ: SRNE) took over ACEA Therapeutics Inc for $38 Million. The company issued 5.519 million common shares to satisfy ACEA’s outstanding...
Aeterna Zentaris Inc. (NASDAQ:AEZS) Enters Strategic Distribution Agreement For Marketing Of Macimorelin In Middle...
Aeterna Zentaris Inc. (NASDAQ:AEZS) and Megapharm Ltd entered an exclusive distribution and quality agreement for commercialization of Aeterna Zentalis’ oral ghrelin agonist, macimorelin. Megapharm...
Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) Publishes The Findings From Its Investigator Sponsored Study Involving Patients...
Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) ended September with an announcement through which it revealed the results of its investigator-sponsored study evaluating patients with mild COVID-19.
The...
MAIA Biotechnology (NYSE: MAIA) surges as investors take notice of its presentation at prestigious...
In recent weeks, MAIA Biotechnology (NYSE: MAIA) has garnered significant attention from investors and analysts alike. The company, focused on developing innovative...
NIO Inc. (NIO) stock pull back may get investors excited
NIO Inc. (NIO) opened at $42.25 and traded between the range of 41.64 - 43.30 . The stock currently has a 52 week range...
MAKE IT MODERN
